Products & R&D
-
Pipeline

Pipeline

Description:
Description:
Information
Fields Products Target IP Indications Preclinical IND Phase Ⅰ Phase Ⅱ Phase Ⅲ NDA Aprroval
Chronic diseases CGT-8012 DPP4 Global Diabetes
 
Anti-cancer CGT-6321 FGFR/VEGFR Global Solid tumours
 
Anti-cancer CGT-9475 ALK Global Non-small-cell lung cancer
 
Anti-cancer CGT-1881 CXCR4 Global Blood cancer
 
Anti-cancer CGT-1967 CDK Global Blood cancer
 
Chronic diseases CGT-2201 DPP4/SGLT2 Global Diabetes
 
Rare Diseases Teriflunomide DHODH Mainland China Relapsing multiple sclerosis
 

Contact Us

Add:Room 101, Bld C11, 218 Xinghu Rd,Suzhou industrial Park,China, 215123

Tel: +86-512-62956960(Recruitment)

         +86-512-62956961(marketing)

Copyright © 2022  CGeneTech (Suzhou, China) Co., Ltd.  All rights reserved.  苏ICP备2022006552号-1  Powered by 300.cn  SEO